Clinical Trial Update: fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases [NA]

View source ↗

Summary

The fREEDOM trial for Resonance for Early Detection Of Breast Cancer Metastases is currently recruiting participants with invasive breast cancer, including HER2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Invasive Breast Cancer, HER2-positive Breast Cancer | NA | Status: RECRUITING